119 related articles for article (PubMed ID: 8172401)
1. Some genetic, clinical and immunologic interrelations in schistosomiasis mansoni.
Assaad-Khalil SH; Helmy MA; Zaki A; Mikhail MM; el-Hai MA; el-Sawy M
Ann Biol Clin (Paris); 1993; 51(6):619-26. PubMed ID: 8172401
[TBL] [Abstract][Full Text] [Related]
2. Immune responses during human schistosomiasis. XII. Differential responsiveness in patients with hepatosplenic disease.
Colley DG; Garcia AA; Lambertucci JR; Parra JC; Katz N; Rocha RS; Gazzinelli G
Am J Trop Med Hyg; 1986 Jul; 35(4):793-802. PubMed ID: 3089040
[TBL] [Abstract][Full Text] [Related]
3. Human schistosomiasis mansoni: immune responses during acute and chronic phases of the infection.
Caldas IR; Campi-Azevedo AC; Oliveira LF; Silveira AM; Oliveira RC; Gazzinelli G
Acta Trop; 2008; 108(2-3):109-17. PubMed ID: 18577364
[TBL] [Abstract][Full Text] [Related]
4. Cell mediated immune (CMI) responsiveness to soluble egg antigen (SEA) and its relation to the occurrence of schistosomal hepatosplenic disease in patients with schistosomiasis mansoni.
Helmy-Khalil S; Fahmy MH; Ghanem MH; Said M; El Sawy M; Nofal M; Awadalla HN; Youssef M; Mucke D; Brock J
Tropenmed Parasitol; 1979 Dec; 30(4):426-8. PubMed ID: 538816
[TBL] [Abstract][Full Text] [Related]
5. Serodiagnosis of Schistosoma mansoni infections in an endemic area of Burkina Faso: performance of several immunological tests with different parasite antigens.
Sorgho H; Bahgat M; Poda JN; Song W; Kirsten C; Doenhoff MJ; Zongo I; Ouédraogo JB; Ruppel A
Acta Trop; 2005 Feb; 93(2):169-80. PubMed ID: 15652331
[TBL] [Abstract][Full Text] [Related]
6. The role of porto-systemic shunts in the specific humoral immune response in patients with schistosomal hepatic fibrosis.
Helmy-Khalil S; Khalil SA; el Sawy M; Youssef M; el Kader MA; el Hallous D; el Balassy F; Souka M; el Girby A; Fahmy MH
Ann Biol Clin (Paris); 1985; 43(6):856-60. PubMed ID: 3938625
[TBL] [Abstract][Full Text] [Related]
7. Dichotomies in the reactivity to worm antigen in human schistosomiasis mansoni.
Ellner JJ; Olds GR; Osman GS; El Kholy A; Mahmoud AA
J Immunol; 1981 Jan; 126(1):309-12. PubMed ID: 7451972
[TBL] [Abstract][Full Text] [Related]
8. CD4 and CD8 distribution profile in individuals infected by Schistosoma mansoni.
Oliveira-Prado R; Caldas IR; Teixeira-Carvalho A; Andrade MV; Gazzinelli A; Correa-Oliveira R; Cunha-Melo JR
Scand J Immunol; 2009 Jun; 69(6):521-8. PubMed ID: 19439013
[TBL] [Abstract][Full Text] [Related]
9. Humoral immune responses in human hepatosplenic schistosomiasis mansoni.
Goodgame RW; Colley DG; Draper CC; Lewis FA; McLaren ML; Pelley RP
Am J Trop Med Hyg; 1978 Nov; 27(6):1174-80. PubMed ID: 727322
[TBL] [Abstract][Full Text] [Related]
10. Study of eosinophilia in relation to serum IgE level and cell mediated immunity (CMI) to soluble egg antigen (SEA) in human schistosomiasis mansoni.
Khalil SH; Khalil H; Fahmy MH; Said M; el Sawy M; Nofal M; Amara F; Taky M; Brock J; Arab M
Allerg Immunol (Leipz); 1985; 31(2):105-8. PubMed ID: 3161309
[TBL] [Abstract][Full Text] [Related]
11. Familial resemblance in humoral immune response to defined and crude Schistosoma mansoni antigens in an endemic area in Brazil.
Bethony J; Silveira AM; Alves-Oliveira LF; Thakur A; Gazzinelli G; Correa-Oliveira R; LoVerde PT
J Infect Dis; 1999 Nov; 180(5):1665-73. PubMed ID: 10515830
[TBL] [Abstract][Full Text] [Related]
12. Suppression splenic T lymphocytes in human hepatosplenic Schistosomiasis mansoni.
Ellner JJ; Olds GR; Kamel R; Osman GS; el-Kholy A; Mahmoud AA
J Immunol; 1980 Jul; 125(1):308-12. PubMed ID: 6966656
[TBL] [Abstract][Full Text] [Related]
13. Immuno-metabolic factors in schistosomal hepatic fibrosis modulating atherogenesis.
Assaad-Khalil SH; Lachine N; Sidrak M; Amara F; Jacotot B; Fahmy MH
Ann Biol Clin (Paris); 1992; 50(10-11):697-701. PubMed ID: 1306953
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulatory effects of curcumin treatment on murine schistosomiasis mansoni.
Allam G
Immunobiology; 2009; 214(8):712-27. PubMed ID: 19249123
[TBL] [Abstract][Full Text] [Related]
15. INF-gamma, IL-5 and IgE profiles in chronic schistosomiasis mansoni Egyptian patients with or without hepatitis C infection.
Makhlouf LM; Serwah Ael-H; Abd El-Hamid Ael D; Hussein EM; Saad RM
J Egypt Soc Parasitol; 2006 Apr; 36(1):177-96. PubMed ID: 16605110
[TBL] [Abstract][Full Text] [Related]
16. Immunogenetic analysis of patients with post-schistosomal liver cirrhosis in man.
Ohta N; Nishimura YK; Iuchi M; Sasazuki T
Clin Exp Immunol; 1982 Sep; 49(3):493-9. PubMed ID: 6816494
[TBL] [Abstract][Full Text] [Related]
17. Study of cell mediated immune responsiveness to soluble egg antigen and phytohaemagglutinin using the lymphoblast transformation test in human schistosomiasis mansoni in Egypt.
Khalil H; Fahmy MH; Ghanem MH; Said M; El Sawy M; Nofal M; Awadalla HN; Youssef M; Mucke D; Brock J; Bedwany R; Khalil T
Rev Inst Med Trop Sao Paulo; 1981; 23(3):97-101. PubMed ID: 7280480
[No Abstract] [Full Text] [Related]
18. Eosinophil activation status, cytokines and liver fibrosis in Schistosoma mansoni infected patients.
Silveira-Lemos D; Teixeira-Carvalho A; Martins-Filho OA; Alves Oliveira LF; Costa-Silva MF; Matoso LF; de Souza LJ; Gazzinelli A; Corrêa-Oliveira R
Acta Trop; 2008; 108(2-3):150-9. PubMed ID: 18550021
[TBL] [Abstract][Full Text] [Related]
19. Elevated type 1, diminished type 2 cytokines and impaired antibody response are associated with hepatotoxicity and mortalities during Schistosoma mansoni infection of CD4-depleted mice.
Fallon PG; Richardson EJ; Smith P; Dunne DW
Eur J Immunol; 2000 Feb; 30(2):470-80. PubMed ID: 10671202
[TBL] [Abstract][Full Text] [Related]
20. T cell phenotype alterations in hepatosplenic schistosomiasis mansoni normalize after chemotherapy.
Zwingenberger K; Harms G; Vergetti de Siqueira JG; Correia Dacal AR; Jansen-Rosseck R; Bienzle U; Feldmeier H
Immunobiology; 1989 Oct; 179(4-5):342-52. PubMed ID: 2515152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
